PDB Short entry for 3DS5 HEADER VIRAL PROTEIN 11-JUL-08 3DS5 TITLE HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (N183A) COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 CAPSID PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, UNP RESIDUES 278-363; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11698; SOURCE 5 STRAIN: NL4-3; SOURCE 6 GENE: GAG; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODONPLUS-RIL; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET11C KEYWDS HIV, CAPSID, MUTANT, ASSEMBLY, POLYPROTEIN, MAINLY ALPHA, VIRAL KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.IGONET,M.C.VANEY,F.A.REY REVDAT 8 30-AUG-23 3DS5 1 REMARK REVDAT 7 20-OCT-21 3DS5 1 SEQADV REVDAT 6 25-OCT-17 3DS5 1 REMARK REVDAT 5 13-OCT-09 3DS5 1 TITLE REVDAT 4 24-FEB-09 3DS5 1 VERSN REVDAT 3 25-NOV-08 3DS5 1 JRNL REVDAT 2 09-SEP-08 3DS5 1 JRNL REVDAT 1 02-SEP-08 3DS5 0 JRNL AUTH V.BARTONOVA,S.IGONET,J.STICHT,B.GLASS,A.HABERMANN,M.C.VANEY, JRNL AUTH 2 P.SEHR,J.LEWIS,F.A.REY,H.G.KRAUSSLICH JRNL TITL RESIDUES IN THE HIV-1 CAPSID ASSEMBLY INHIBITOR BINDING SITE JRNL TITL 2 ARE ESSENTIAL FOR MAINTAINING THE ASSEMBLY-COMPETENT JRNL TITL 3 QUATERNARY STRUCTURE OF THE CAPSID PROTEIN. JRNL REF J.BIOL.CHEM. V. 283 32024 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18772135 JRNL DOI 10.1074/JBC.M804230200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH F.TERNOIS,J.STICHT,S.DUQUERROY,H.-G.KRAUSSLICH,F.A.REY REMARK 1 TITL THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN IN COMPLEX WITH A REMARK 1 TITL 2 VIRUS ASSEMBLY INHIBITOR REMARK 1 REF NAT.STRUCT.MOL.BIOL. V. 12 678 2005 REMARK 1 REFN ISSN 1545-9993 REMARK 1 PMID 16041386 REMARK 1 DOI 10.1038/NSMB967 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.9 REMARK 3 NUMBER OF REFLECTIONS : 12892 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 677 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 471 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 41.55 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE SET COUNT : 18 REMARK 3 BIN FREE R VALUE : 0.3390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2292 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 22 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.68000 REMARK 3 B22 (A**2) : -0.81000 REMARK 3 B33 (A**2) : -0.85000 REMARK 3 B12 (A**2) : 0.78000 REMARK 3 B13 (A**2) : 0.77000 REMARK 3 B23 (A**2) : -1.57000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.451 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.293 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.193 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.104 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2328 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3144 ; 1.617 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 288 ; 6.339 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 104 ;33.755 ;25.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 432 ;20.618 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;23.891 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 356 ; 0.092 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1728 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1070 ; 0.227 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1630 ; 0.299 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 88 ; 0.136 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 52 ; 0.244 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.210 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1497 ; 0.809 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2348 ; 1.427 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 940 ; 2.301 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 796 ; 3.761 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 3 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : B A REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 B 149 B 221 2 REMARK 3 1 A 149 A 221 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 B (A): 292 ; 0.02 ; 0.05 REMARK 3 MEDIUM POSITIONAL 1 B (A): 281 ; 0.34 ; 0.50 REMARK 3 TIGHT THERMAL 1 B (A**2): 292 ; 0.08 ; 0.50 REMARK 3 MEDIUM THERMAL 1 B (A**2): 281 ; 0.45 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : C A REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 C 149 C 221 2 REMARK 3 1 A 149 A 221 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 C (A): 292 ; 0.02 ; 0.05 REMARK 3 MEDIUM POSITIONAL 2 C (A): 281 ; 0.11 ; 0.50 REMARK 3 TIGHT THERMAL 2 C (A**2): 292 ; 0.07 ; 0.50 REMARK 3 MEDIUM THERMAL 2 C (A**2): 281 ; 0.42 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 3 REMARK 3 CHAIN NAMES : C A D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 C 149 D 221 2 REMARK 3 1 A 149 A 221 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 3 D (A): 292 ; 0.04 ; 0.05 REMARK 3 MEDIUM POSITIONAL 3 D (A): 281 ; 0.24 ; 0.50 REMARK 3 TIGHT THERMAL 3 D (A**2): 292 ; 0.08 ; 0.50 REMARK 3 MEDIUM THERMAL 3 D (A**2): 281 ; 0.46 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3DS5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1000048419. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAY-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.044 REMARK 200 MONOCHROMATOR : SI(111) MONOCHROMATOR REMARK 200 OPTICS : DYNAMICALLY BENDABLE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13571 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 42.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.3 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.02500 REMARK 200 R SYM (I) : 0.02500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 36.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 43.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.13900 REMARK 200 R SYM FOR SHELL (I) : 0.13900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1A80 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 100MM AMMONIUM ACETATE, REMARK 280 10MM MGCL2, PH 4.6, EVAPORATION, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 146 REMARK 465 PRO A 147 REMARK 465 THR A 148 REMARK 465 GLY A 222 REMARK 465 GLY A 223 REMARK 465 PRO A 224 REMARK 465 GLY A 225 REMARK 465 HIS A 226 REMARK 465 LYS A 227 REMARK 465 ALA A 228 REMARK 465 ARG A 229 REMARK 465 VAL A 230 REMARK 465 LEU A 231 REMARK 465 SER B 146 REMARK 465 PRO B 147 REMARK 465 THR B 148 REMARK 465 GLY B 222 REMARK 465 GLY B 223 REMARK 465 PRO B 224 REMARK 465 GLY B 225 REMARK 465 HIS B 226 REMARK 465 LYS B 227 REMARK 465 ALA B 228 REMARK 465 ARG B 229 REMARK 465 VAL B 230 REMARK 465 LEU B 231 REMARK 465 SER C 146 REMARK 465 PRO C 147 REMARK 465 THR C 148 REMARK 465 GLY C 222 REMARK 465 GLY C 223 REMARK 465 PRO C 224 REMARK 465 GLY C 225 REMARK 465 HIS C 226 REMARK 465 LYS C 227 REMARK 465 ALA C 228 REMARK 465 ARG C 229 REMARK 465 VAL C 230 REMARK 465 LEU C 231 REMARK 465 SER D 146 REMARK 465 PRO D 147 REMARK 465 THR D 148 REMARK 465 GLY D 222 REMARK 465 GLY D 223 REMARK 465 PRO D 224 REMARK 465 GLY D 225 REMARK 465 HIS D 226 REMARK 465 LYS D 227 REMARK 465 ALA D 228 REMARK 465 ARG D 229 REMARK 465 VAL D 230 REMARK 465 LEU D 231 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 188 -80.33 -113.84 REMARK 500 THR B 188 -81.16 -116.10 REMARK 500 THR C 188 -82.43 -116.72 REMARK 500 THR D 188 -80.27 -118.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3DS4 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S) IN COMPLEX WITH AN REMARK 900 INHIBITOR OF PARTICLE ASSEMBLY (CAI) REMARK 900 RELATED ID: 3DS2 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (Y169A) REMARK 900 RELATED ID: 3DS3 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (Y169A) IN COMPLEX WITH AN REMARK 900 INHIBITOR OF PARTICLE ASSEMBLY (CAI) REMARK 900 RELATED ID: 3DTJ RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (E187A) REMARK 900 RELATED ID: 3DS1 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (E187A) IN COMPLEX WITH AN REMARK 900 INHIBITOR OF PARTICLE ASSEMBLY (CAI) REMARK 900 RELATED ID: 3DS0 RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (N183A) IN COMPLEX WITH AN REMARK 900 INHIBITOR OF PARTICLE ASSEMBLY (CAI) REMARK 900 RELATED ID: 3DPH RELATED DB: PDB REMARK 900 HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S) DBREF 3DS5 A 146 231 UNP Q72497 Q72497_9HIV1 278 363 DBREF 3DS5 B 146 231 UNP Q72497 Q72497_9HIV1 278 363 DBREF 3DS5 C 146 231 UNP Q72497 Q72497_9HIV1 278 363 DBREF 3DS5 D 146 231 UNP Q72497 Q72497_9HIV1 278 363 SEQADV 3DS5 ALA A 183 UNP Q72497 ASN 315 ENGINEERED MUTATION SEQADV 3DS5 ALA B 183 UNP Q72497 ASN 315 ENGINEERED MUTATION SEQADV 3DS5 ALA C 183 UNP Q72497 ASN 315 ENGINEERED MUTATION SEQADV 3DS5 ALA D 183 UNP Q72497 ASN 315 ENGINEERED MUTATION SEQRES 1 A 86 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 A 86 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 A 86 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ALA TRP SEQRES 4 A 86 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 A 86 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 A 86 LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL GLY GLY SEQRES 7 A 86 PRO GLY HIS LYS ALA ARG VAL LEU SEQRES 1 B 86 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 B 86 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 B 86 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ALA TRP SEQRES 4 B 86 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 B 86 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 B 86 LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL GLY GLY SEQRES 7 B 86 PRO GLY HIS LYS ALA ARG VAL LEU SEQRES 1 C 86 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 C 86 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 C 86 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ALA TRP SEQRES 4 C 86 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 C 86 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 C 86 LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL GLY GLY SEQRES 7 C 86 PRO GLY HIS LYS ALA ARG VAL LEU SEQRES 1 D 86 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 D 86 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 D 86 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ALA TRP SEQRES 4 D 86 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 D 86 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 D 86 LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL GLY GLY SEQRES 7 D 86 PRO GLY HIS LYS ALA ARG VAL LEU FORMUL 5 HOH *22(H2 O) HELIX 1 1 SER A 149 ILE A 153 5 5 HELIX 2 2 PRO A 160 GLU A 175 1 16 HELIX 3 3 SER A 178 THR A 188 1 11 HELIX 4 4 THR A 188 ASN A 193 1 6 HELIX 5 5 ASN A 195 GLY A 206 1 12 HELIX 6 6 THR A 210 GLN A 219 1 10 HELIX 7 7 SER B 149 ILE B 153 5 5 HELIX 8 8 PRO B 160 GLU B 175 1 16 HELIX 9 9 SER B 178 THR B 188 1 11 HELIX 10 10 THR B 188 ASN B 193 1 6 HELIX 11 11 ASN B 195 GLY B 206 1 12 HELIX 12 12 THR B 210 GLN B 219 1 10 HELIX 13 13 SER C 149 ILE C 153 5 5 HELIX 14 14 PRO C 160 GLU C 175 1 16 HELIX 15 15 SER C 178 THR C 188 1 11 HELIX 16 16 THR C 188 ASN C 193 1 6 HELIX 17 17 ASN C 195 GLY C 206 1 12 HELIX 18 18 THR C 210 GLN C 219 1 10 HELIX 19 19 SER D 149 ILE D 153 5 5 HELIX 20 20 PRO D 160 GLU D 175 1 16 HELIX 21 21 SER D 178 THR D 188 1 11 HELIX 22 22 THR D 188 ASN D 193 1 6 HELIX 23 23 ASN D 195 GLY D 206 1 12 HELIX 24 24 THR D 210 CYS D 218 1 9 CRYST1 51.359 51.321 51.358 109.20 109.63 109.55 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019471 0.006912 0.011964 0.00000 SCALE2 0.000000 0.020677 0.011848 0.00000 SCALE3 0.000000 0.000000 0.023826 0.00000